key: cord-0892092-68nv5c5o
authors: Kollias, Anastasios; Kyriakoulis, Konstantinos G.; Stergiou, George S.
title: COVID-19 and heart injury: Appropriate methodology is crucial for assessing the emerging evidence
date: 2020-06-03
journal: Prog Cardiovasc Dis
DOI: 10.1016/j.pcad.2020.06.001
sha: e39fb5670442f5162375ed42fa812c1c8c5b10f1
doc_id: 892092
cord_uid: 68nv5c5o

nan

J o u r n a l P r e -p r o o f Title: COVID-19 and Heart Injury: Appropriate Methodology is Crucial for Assessing the Emerging Evidence

To the Editor:

We read with interest the article by Li et al in the Prog Cardiovasc Dis journal regarding the evidence on the association between COVID-19 and cardiac injury. 1 The authors performed a systematic review and subsequent meta-analyses showing that: (i) cardiac biomarkers are higher in COVID-19 patients with severe disease compared to those without, and (ii) cardiac injury was associated with a pooled risk ratio 3.9 (95% confidence intervals [CI] 2.1, 7.0) for mortality. 1 The authors concluded that physicians need to effectively monitor cardiac function to prevent myocarditis in patients infected with COVID-19. 1 The prompt publication of emerging evidence is crucial for our understanding of the natural course of COVID-19 and most importantly for the risk stratification of these patients. In this context, rapid analyses and review processes are needed. Cardiac injury appears to be common in patients with severe COVID-19 and influences their prognosis. Multiple mechanisms including both ischemic and non-ischemic ones have been implicated in its aetiology.

J o u r n a l P r e -p r o o f (i) One third of the studies included in the meta-analysis reporting data on the prognostic relevance of cardiac injury in terms of mortality have not been subjected to peerreview. [2] [3] [4] (ii) There seems to be overlapping in the populations of the included studies since there was overlapping in the recruitment hospitals and investigation periods. [5] [6] [7] [8] (iii) Meta-analysis of the risk ratios for mortality included unadjusted ratios, which considerably influence the key findings. For example, in the study of Shi et al which was the largest one, the unadjusted hazard risk ratio for death was 11.4 (95% CI: 6.7, 19.5) whereas the adjusted ratio was 3.4 (95% CI: 1.6, 7.2) during the time from admission to study endpoint. 9 The abovementioned methodological deficiencies do not undermine the importance and usefulness of the authors' observations and analyses 1 , but are crucial for the accurate quantification of clinical issues aiming to interfere in the natural course of this disease.

The impact of 2019 novel coronavirus on heart injury: A systemic review and Meta-analysis

Clinical features and outcomes of 2019 novel coronavirus-infected patients with cardiac injury. medRxiv

Influence factors of death risk among COVID-19 patients in Wuhan, China: a hospital-based case-cohort study. medRxiv

Myocardial injury is associated with in-hospital mortality of confirmed or suspected COVID-19 in Wuhan, China: A single center retrospective cohort study

Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China